Position in KROS
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$240,185
-$321,383 QoQ
Shares Held
21,756
-21.1% QoQ
Ownership
0.110%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in KROS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FRANKLIN RESOURCES INC holds $9,179,114,031 across 176 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,771,839 | $1,728,352,485 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,347,253 | $1,662,680,977 | |
| 3 | ASND |
Ascendis Pharma A/S
|
1,862,503 | $496,766,798 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
2,040,250 | $491,639,040 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
1,488,394 | $278,746,426 | |
| 6 | INSM |
INSMED Inc
|
2,273,222 | $242,370,927 | |
| 7 | LGND |
Ligand Pharmaceuticals Inc
|
752,044 | $237,713,585 | |
| 8 | ARGX |
Argenx SE
|
224,930 | $208,683,303 |
All Filings in KROS
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $240,185 | 21,756 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $561,568 | 27,582 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $1,388,330 | 87,758 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,766,216 | 132,301 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $390,224 | 38,295 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $4,565,814 | 288,428 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $16,737,747 | 288,234 | Shares | Defined | 2024-11-27 | |
| 2024-06-30 | $18,289,778 | 400,214 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $41,841,641 | 632,049 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $27,809,137 | 699,425 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $15,071,301 | 472,751 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $18,995,134 | 472,751 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $20,186,466 | 472,751 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $22,701,502 | 472,751 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $17,794,183 | 472,998 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $13,065,674 | 472,880 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $21,462,534 | 394,677 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $23,093,194 | 394,688 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $15,612,749 | 394,660 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $16,763,970 | 394,725 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $16,014,017 | 260,179 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $18,349,287 | 260,126 | Shares | Defined | 2021-02-10 | |
| No filing history on record for this holder in this stock. | ||||||